-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … Patients sometimes also use
alternative therapies. … for treatment of ulcerative colitis
Intervention
Helminthic therapy for treatment of ulcerative … nonsurgical therapeutic alternative
for these treatment-refractory patients. … Some noted that this treatment is priced less expensively than some currently approved
UC treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - intervention
[percutaneous transluminal arterial angioplasty and stenting], bypass surgery), and
exercise therapy … Comparator(s): KQ1/KQ2: antiplatelet therapy, antiplatelet therapy and aspirin,
comparison of two … different antiplatelet therapies; KQ3: exercise therapy, endovascular
intervention; KQ4: endovascular … Is endovascular intervention (PTA, stents) more effective than exercise therapy in
Peripheral Artery … At this time, the
benefit of anti-platelet therapy in patients with PAD and the comparative effectiveness
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-future_research.pdf
February 01, 2013 - In these cases, adjunct therapies such as manual therapy, taping,
or transcutaneous electrical nerve … The
same therapies used as adjunct therapies may also be used as stand-alone therapies. … MCIDs in scales were determined for 26 scales, but therapeutic studies did
Examination, Evaluation, … Isometric knee
extension exercise
NCT00701506 Patterned Electrical Neuromuscular Stimulation and Therapeutic … Versus Exercise on Knee Osteoarthritis Procedure: Manual Therapy|Behavioral: Therapeutic Exercise|Behavioral
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of
concurrent standard medical therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of
concurrent standard medical therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - have been
studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement
Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic
use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug
therapy’/exp OR ‘therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … When these therapies fail to achieve
relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter pain
medication, exercise and/or physical therapy … Autologous MSCs have also been given with
other therapies, including platelet-rich plasma (PRP) therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
December 05, 2013 - When these therapies fail
to achieve relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter
pain medication, exercise and/or physical therapy … Autologous MSCs have also been given with other therapies,
including platelet-rich plasma (PRP) therapy … of treatments required. … The cost of one PRP
treatment was purported to be lower than the cost of three hyaluronic acid treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - therapies. … , digital gamified cognitive
therapies, EndeavorRx, play therapy, play-based
interventions, mindfulness-based … ): Specific treatments compared with
other treatments as described above or to no treatment
KQ 3 (monitoring … Therapies"[MeSH] OR "Combined Modality Therapy"[MeSH]
ADHD Systematic Review Protocol … ] OR "alternative therapy"[tiab] OR "alternative therapies"[tiab]
OR "Interpersonal skills training"
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
January 01, 2015 - modalities and therapies. … modalities and therapies. … Enrollment
Addition of Pudendal
Blocks to Pelvic
Floor Physical
Therapy for the
Treatment of Pelvic … Pharmacologic treatment
· In addition to hormonal therapies, the list of research needs should include … Characterize patient healthcare-seeking for alternative treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Rapid diagnosis of sepsis and early initiation of
antibiotic and goal-directed therapies have demonstrated … o Were participants in treatment groups recruited in the same time period? … o Were concurrent/concomitant treatments clearly specified and given
equally to treatment groups? … because they convey the possibility of determining differences in the relative
efficacy of two treatments … Procalcitonin in sepsis and systemic
inflammation: a harmful biomarker and a therapeutic target.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
January 01, 2007 - management era (i.e., since JNC-5 in
19931), what is the evidence on the
effects of aggressive medical therapy … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … What adverse events and complications have
been associated with aggressive medical
therapy or renal artery … Notably, only two trials have compared
angioplasty (without stent placement) with medical
therapy and … alone or medical therapy followed by
angioplasty at 3 months found either no significant
differences
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
September 29, 2011 - their therapeutic goal. … In
addition to aggressive medical therapy, two treatment pathways have emerged for treating
patients … Presentation
Treatment
Optimal medical
therapy PCI* CABG*
STEMI X X
NSTEMI/ unstable angina … Adding the effect of different therapies on cognition. … currently in use (such as specific components of treatments
considered to be ―optimal medical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - Treatment Indications
Two major indications for liver-directed therapies exist:
1. … Current Treatments
Several liver-directed therapies have been developed to treat patients with CRC … and harms of the various palliative treatments. … Comparators
KQ 1 & 2:
• All the therapies will be compared to each other as treatment of patients … o Were concurrent/concomitant treatments clearly specified and given equally to
treatment groups?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - have been
studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement
Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic
use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug
therapy’/exp OR ‘therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - advantage of the incident user design is that it can capture the clinical consequences of an entire
therapeutic … The risk of myocardial infarction associated
with antihypertensive drug therapies. … Adherence to prescribed antihypertensive
drug treatments: longitudinal study of
electronically compiled … Structural accelerated failure time models
for survival analysis in studies with time-
varying treatments … A review of uses
of health care utilization databases for
epidemiologic research on therapeutics.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
January 01, 2009 - devices
Comparator(s): See above interventions and no treatment
Outcome(s): Intermediate outcomes … What is the effectiveness and comparative effectiveness of physical and
rehabilitative treatments available … What are the associated risks, adverse effects, and potential harms of physical and
rehabilitative therapies … There is some indication that
non-pharmacologic therapies are underutilized in patients with OA and … A review
that evaluates the effectiveness of treatments and gaps that remain in the evidence for patient
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
December 01, 2021 - characteristics (cancer type,
treatment type (systemic therapy, radiation, surgery),
stage of disease … cancer diagnosis and initiation of any cancer therapy
(e.g., systemic therapy, radiation, surgery). … (at least in part) w ith cancer therapy (e.g.,
systemic therapy, radiation, surgery), regardless of … (at least in part) w ith cancer
therapy (e.g., systemic therapy, radiation, surgery), regardless of … draft report, the search will be conducted from 2000 to December 2021 to encompass
contemporary cancer treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
November 27, 2012 - In the
former, practitioners move to another therapeutic choice and in the latter,
study subjects drop … Although
therapies may be stopped after 12 to 16
weeks in patients who fail treatment, there
are patients … who are on these therapies
much longer than 16 weeks when therapies
are successful. … Thus, ustekinumab is by far the most convenient therapy. … Amgen has conducted many clinical trials in the
inflammation therapeutic area to demonstrate the safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - diabetes in the
United States.
3,4
Thus, a large segment of the population requires glucose-lowering therapies … insulin
delivery and glucose monitoring for various populations of individuals with diabetes so that
therapeutic … of individuals with diabetes who are
receiving treatment in a usual care setting. … Intensive diabetes treatment and cardiovascular disease in
patients with type 1 diabetes. … Continuous glucose monitoring and intensive treatment of type
1 diabetes.